From: Holmium laser enucleation of the prostate: a 3-year single-center experience of 173 cases
Total number of included patients, N | 173 |
Age, mean (SD) | 71.3 (7.83) |
Age categories | |
50–59 | 10 (5.8) |
60–79 | 138 (79.8) |
80+ | 25 (14.4) |
History of prostatic surgery | 6 (3.5) |
Diabetes | 19 (11) |
Hypertension | 58 (33.5) |
Anticoagulation drug therapy | 72 (41.6) |
Smoking | 35 (20.7) |
PSA before procedure, mean (SD) | 4.1 (0.1–32.6) |
Holep indications | |
Medical treatment failure | 79 (45.7) |
Acute urinary retention after TWOC | 48 (22.7) |
Obstructive acute kidney injury | 22 (12.7) |
Bladder stone | 07 (4) |
Persistent hematuria | 06 (3.5) |
Recurrent prostatitis | 03 (1.7) |
Holep preceding radiotherapy for prostate cancer | 07 (4) |
Pelviuereteric lithiasis | 01 (0.6) |